Neuropsychological Assessment
Neuropsychological Assessment is an intervention with 54 clinical trials. Currently 17 active trials ongoing. Historical success rate of 91.3%.
Success Metrics
Based on 21 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.3%
21 of 23 finished
8.7%
2 ended early
17
trials recruiting
54
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical Treatment
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders
Central Sensitisation in Nociceptive and Neuropathic Pain
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
Clinical Trials (54)
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical Treatment
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders
Central Sensitisation in Nociceptive and Neuropathic Pain
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
Associative Memory in Autism Spectrum Disorder
Resilience and Modification of Brain Control Network Following November 13
Hinting Task for Huntington's Disease
Neuropsychological Patterns of Suicide Ideators and Suicide Attempters
COPD-Related Physiology and the Brain
Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients With Brain Metastases
Neuropsychological Outcome After Cardiac Arrest
PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE
Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline?
Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's Disease
Neuroinflammation in FTLD
Reading Ability in Childhood Obesity
Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease
WHIte MAtter Hyperintensity Shape and Glymphatics
Training Cognition With Neurofeedback After Stroke
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 54